Cargando…

The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER

BACKGROUND: Papillary thyroid cancer (PTC) is a common endocrine malignancy with relatively good prognosis. Radioactive iodine (RAI) is considered effective for patients with total or nearly total thyroidectomy, but the beneficial effects of RAI are still controversial. MATERIALS AND METHODS: To det...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Jianing, Kong, Deguang, Cui, Qiuxia, Wang, Kun, Zhang, Dan, Liao, Xing, Gong, Yan, Wu, Gaosong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016280/ https://www.ncbi.nlm.nih.gov/pubmed/29950860 http://dx.doi.org/10.2147/OTT.S160752

Ejemplares similares

Racial disparities of differentiated thyroid carcinoma: clinical behavior, treatments, and long-term outcomes
por: Tang, Jianing, et al.
Publicado: (2018)

Bioinformatic analysis and identification of potential prognostic microRNAs and mRNAs in thyroid cancer
por: Tang, Jianing, et al.
Publicado: (2018)

Surgical management for follicular variant of papillary thyroid carcinoma
por: Tang, Jianing, et al.
Publicado: (2017)

Prognostic Genes of Breast Cancer Identified by Gene Co-expression Network Analysis
por: Tang, Jianing, et al.
Publicado: (2018)

Radioactive iodine in low- to intermediate-risk papillary thyroid cancer
por: Zhao, Hengqiang, et al.
Publicado: (2022)

Parathyroid autotransplantation at a novel site for better evaluation of the grafted gland function: study protocol for a prospective, randomized controlled trial
por: Cui, Qiuxia, et al.
Publicado: (2019)

Radioactive Iodine Therapy Decreases Recurrence in Thyroid Papillary Microcarcinoma
por: Creach, Kimberly M., et al.
Publicado: (2012)

Overexpression of ASPM, CDC20, and TTK Confer a Poorer Prognosis in Breast Cancer Identified by Gene Co-expression Network Analysis
por: Tang, Jianing, et al.
Publicado: (2019)

A prognostic 10‐lncRNA expression signature for predicting the risk of tumour recurrence in breast cancer patients
por: Tang, Jianing, et al.
Publicado: (2019)

Co-transplantation with adipose-derived cells to improve parathyroid transplantation in a mice model
por: Cui, Qiuxia, et al.
Publicado: (2020)

Radioactive Iodine Resistant Papillary Thyroid Cancer “Redifferentiated” With Dabrafenib
por: Zayouna, Christine, et al.
Publicado: (2021)

SIX1 Activates STAT3 Signaling to Promote the Proliferation of Thyroid Carcinoma via EYA1
por: Kong, Deguang, et al.
Publicado: (2019)

Radioactive Iodine Therapy in Patients With Thyroid Carcinoma With Distant Metastases: A SEER-Based Study
por: Li, Chenyuan, et al.
Publicado: (2020)

The Genomic Landscape of Radioactive Iodine Refractory and Avid Papillary Thyroid Carcinomas
por: Al-Kuraya, Khawla Sami, et al.
Publicado: (2021)

The benefits of radioactive iodine ablation for patients with intermediate-risk papillary thyroid cancer
por: Wang, Xiaofei, et al.
Publicado: (2020)

Patient-Derived Papillary Thyroid Cancer Organoids for Radioactive Iodine Refractory Screening
por: Sondorp, Luc H.J., et al.
Publicado: (2020)

Responses to the First Radioactive Iodine Treatment After Targeted Therapy for Aggressive Papillary Thyroid Cancers
por: Soe, Myat Han, et al.
Publicado: (2021)

Changes in Gut Microbiota and Metabolites in Papillary Thyroid Carcinoma Patients Following Radioactive Iodine Therapy
por: Li, Wanting, et al.
Publicado: (2023)

A prospective cohort study of novel functional types of parathyroid glands in thyroidectomy: In situ preservation or auto-transplantation?
por: Cui, Qiuxia, et al.
Publicado: (2016)

“Adjuvant Radioactive iodine 133 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience”
por: AL-Qahtani, Khalid Hussain, et al.
Publicado: (2015)

Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer
por: Liu, Lina, et al.
Publicado: (2022)

TNF-α May Exert Different Antitumor Effects in Response to Radioactive Iodine Therapy in Papillary Thyroid Cancer with/without Autoimmune Thyroiditis
por: Gheorghe, Dan Cristian, et al.
Publicado: (2021)

An estrogen receptor (ER)‐related signature in predicting prognosis of ER‐positive breast cancer following endocrine treatment
por: Tang, Jianing, et al.
Publicado: (2019)

Erratum to: Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience
por: AL-Qahtani, Khalid Hussain, et al.
Publicado: (2016)

Thrombotic Microangiopathy with Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma
por: Hyogo, Yasuko, et al.
Publicado: (2018)

Assessment of different markers of ovarian reserve in women with papillary thyroid cancer treated with radioactive iodine
por: Adamska, Agnieszka, et al.
Publicado: (2021)

Treatment Response following Radioactive Iodine Therapy in Miliary versus Macronodular Pulmonary Metastases in Papillary Thyroid Carcinoma
por: Sunny, S. S., et al.
Publicado: (2022)

BRAF mutation may predict higher necessity of postoperative radioactive iodine ablation in papillary thyroid cancer
por: Han, Sang-Ah, et al.
Publicado: (2014)

SAT569 Papillary Thyroid Carcinoma With Renal Metastasis Treated With Radioactive Iodine: A Case Report
por: Apa-Ap, Archimedes Almasol, et al.
Publicado: (2023)

Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome
por: Lukovic, Jelena, et al.
Publicado: (2021)

Low Iodine Diet for Preparation for Radioactive Iodine Therapy in Differentiated Thyroid Carcinoma in Korea
por: Chung, Jae Hoon
Publicado: (2013)

Radioactive Iodine Therapy of Differentiated Thyroid Carcinoma: Redesigning the Paradigm
por: Goldsmith, Stanley J.
Publicado: (2017)

Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
por: Liu, Jierui, et al.
Publicado: (2019)

Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis
por: Wang, Chen, et al.
Publicado: (2017)

Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer - a randomized controlled trial
por: Sawka, Anna M, et al.
Publicado: (2010)

Radioactive Iodine Ablation Decrease Recurrences in Papillary Thyroid Microcarcinoma with Lateral Lymph Node Metastasis in Chinese Patients
por: Xue, Shuai, et al.
Publicado: (2017)

Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to Treatment: Total Thyroidectomy with or without Radioactive Iodine Ablation
por: Ahn, Jonghwa, et al.
Publicado: (2020)

APOBEC SBS13 Mutational Signature—A Novel Predictor of Radioactive Iodine Refractory Papillary Thyroid Carcinoma
por: Siraj, Sarah, et al.
Publicado: (2022)

Association between excessive chronic iodine exposure and the occurrence of papillary thyroid carcinoma
por: Huang, Fengyan, et al.
Publicado: (2020)

Identification of Radioactive Iodine Refractory Differentiated Thyroid Cancer
por: Mu, Zhuan-Zhuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eic3fgtr6n50nlbl6nuaqvs6qh